All articles

An ESC/EAPCI consensus statement on renal denervation; a debate on the future of transcatheter mitral valve replacement; a mini focus on interventional pharmacology, from P2Y12 inhibitors to evolocumab; impact of non-fatal periprocedural major adverse events on ten-year mortality; pathologic responses to abluminal biodegradable versus circumferential durable polymer-coated DES; and more

Capodanno D

March 20, 2023

Clopidogrel: still king of the ring for elective percutaneous coronary intervention!

Montalescot G, Ferrante A

March 20, 2023 | 10.4244/EIJ-E-23-00003

Effects of PCSK9 inhibitors on platelet function

Räber L, Ueki Y

March 20, 2023 | 10.4244/EIJ-E-23-00005

Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial

Lansky A, Ahmad Y

March 20, 2023 | 10.4244/EIJ-E-23-00004

Periprocedural adverse events after revascularisation: the importance of getting off to a good start

Gaudino M, Dimagli A

March 20, 2023 | 10.4244/EIJ-E-22-00054

Transcatheter mitral valve replacement will remain a niche therapy: pros and cons

Cohen D, Ludwig S, Piazza N

March 20, 2023 | 10.4244/EIJ-E-22-00044

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Barbato E, Azizi M, Schmieder RE, Lauder L, Böhm M, Brouwers S, Bruno RM, Dudek D, Kahan T, Kandzari D, Lüscher T, Parati G, Pathak A, Ribichini F, Schlaich M, Sharp A, Sudano I, Volpe M, Tsioufis C, Wijns W, Mahfoud F

March 20, 2023 | 10.4244/EIJ-D-22-00723

Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes

Koshy A, Giustino G, Sartori S, Hooda A, Feng Y, Snyder C, Dasgupta S, Kumar K, Krishnamoorthy-Melarcode P, Sweeny J, Khera S, Serrao G, Sharma R, Dangas G, Kini A, Mehran R, Sharma S

March 20, 2023 | 10.4244/EIJ-D-22-00654

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study

Franchi F, Ortega-Paz L, Rollini F, Been L, Rivas A, Maaliki N, Zhou X, Pineda A, Suryadevara S, Soffer D, Zenni M, Angiolillo D

March 20, 2023 | 10.4244/EIJ-D-22-00719

Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry

Gargiulo G, Marenna A, Sperandeo L, Manzi L, Avvedimento M, Simonetti F, Canonico M, Paolillo R, Spinelli A, Borgia F, Diserafino L, Franzone A, Stabile E, Piccolo R, Cirillo P, Valgimigli M, Esposito G

March 20, 2023 | 10.4244/EIJ-D-22-00594

Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study

Kordis P, Bozic Mijovski M, Berden J, Steblovnik K, Blinc A, Noc M

March 20, 2023 | 10.4244/EIJ-D-22-00675

Impact of periprocedural major adverse events on 10-year mortality after revascularisation

Kotoku N, Serruys P, Ninomiya K, Soo A, Masuda S, Kageyama S, Revaiah P, Mack M, Holmes DR, Morice M, Davierwala P, Mohr F, Milojevic M, Kappetein A, Garg S, Onuma Y

March 20, 2023 | 10.4244/EIJ-D-22-00681

Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study

Kawagoe Y, Otsuka F, Onozuka D, Ishibashi-Ueda H, Ikeda Y, Ohta-Ogo K, Matsumoto M, Amemiya K, Asaumi Y, Kataoka Y, Nishimura K, Miyamoto Y, Noguchi T, Finn A, Virmani R, Hatakeyama K, Yasuda S

March 20, 2023 | 10.4244/EIJ-D-22-00650

Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

Minten L, Bennett J, Dubois C

March 20, 2023 | 10.4244/EIJ-D-22-00998

Reply: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?

Sabbah M, Lønborg J, Olsen NT, Engstrøm T

March 20, 2023 | 10.4244/EIJ-D-22-01031

Impact of early changes in cardiac damage following transcatheter aortic valve implantation

Zhou Y, Zhu Q, Lin X, Li H, Pu Z, Liu X, Wang J

March 17, 2023 | 10.4244/EIJ-D-22-00817

Posterior pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of 25 randomised controlled trials

Abdelaziz A, Hafez AH, Elaraby A, Roshdy MR, Abdelaziz M, Eltobgy MA, Elsayed H, El-Samahy M, Elbehbeh NA, Philip KG, Abdelaty AM, Rizk MA, Al-Tawil M, AboElfarh HE, Ramadan A, Ghaith HS, Wahsh EA, Abdelazeem B, Fayed B

March 16, 2023 | 10.4244/EIJ-D-22-00948

One-year outcomes of transcatheter tricuspid valve repair with the Mistral device

Piayda K, Bertog S, Steffan J, Ilioska-Damköhler P, Beeri R, Sievert K, Sievert H, Yaron I, Danenberg HD

March 13, 2023 | 10.4244/EIJ-D-22-01032

Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study

Sondergaard L, Walton AS, Worthley SG, Smith D, Chehab B, Manoharan G, Yong G, Bedogni F, Bates N, Reardon MJ

March 9, 2023 | 10.4244/EIJ-D-22-01108

One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry

Cannata S, Gandolfo C, Ribichini F, van Mieghem N, Buccheri S, Barbanti M, Berti S, Teles RC, Bartorelli AL, Musumeci G, Piva T, Nombela-Franco L, La Spina K, Palmerini T, Adrichem R, Esposito A, Lopes P, Olivares P, Annibali G, Nicolini E, Marroquin L, Tamburino C, Tarantini G, Saia F

March 7, 2023 | 10.4244/EIJ-D-22-01022